Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase NA 1Phase 3 1Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 12Stomach Neoplasms 10Colorectal Neoplasms 9Colonic Neoplasms 8Pancreatic Neoplasms 5Carcinoma, Hepatocellular 4Esophageal Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Peritoneal Neoplasms 1Pathologic Complete Response 1Neoplastic Cells, Circulating 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, Large B-Cell, Diffuse 1Locally Advanced Rectal Cancer 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Colonic Diseases 1Appendiceal Neoplasms 1Advanced Primary Liver Cancer 1Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction 1Adenocarcinoma 1

Interventions

irinotecan sucrosofate 1Oxaliplatin 1Fluorouracil 1Diathermy 1Combined Modality Therapy 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Locally Advanced Rectal Cancer × Oxaliplatin × Clear all
NCT06894797 2025-03-25

Preoperative Chemoradiotherapy Combined With Consolidation or Induction NALIRIFOX in Rectal Cancer.

Peking University Cancer Hospital & Institute

Phase NA Recruiting
68 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡